5/5/2026

Iohexol Injection

Products Affected - Description

- Omnipaque solution for injection, GE Healthcare, 300 mg/mL, 100 mL +PLUSPAK bottle, 10 count, NDC 00407-1413-63
- Omnipaque solution for injection, GE Healthcare, 300 mg/mL, 150 mL fill in 200 mL +PLUSPAK bottle, 10 count, NDC 00407-1413-65
- Omnipaque solution for injection, GE Healthcare, 300 mg/mL, 30 mL fill in 50 mL +PLUSPAK bottle, 10 count, NDC 00407-1413-59
- Omnipaque solution for injection, GE Healthcare, 300 mg/mL, 50 mL +PLUSPAK bottle, 10 count, NDC 00407-1413-61
- Omnipaque solution for injection, GE Healthcare, 300 mg/mL, 500 mL +PLUSPAK bottle, 10 count, NDC 00407-1413-72
- Omnipaque solution for injection, GE Healthcare, 350 mg/mL, 100 mL +PLUSPAK bottle, 10 count, NDC 00407-1414-91
- Omnipaque solution for injection, GE Healthcare, 350 mg/mL, 150 mL fill in 200 mL +PLUSPAK bottle, 10 count, NDC 00407-1414-93
- Omnipaque solution for injection, GE Healthcare, 350 mg/mL, 200 mL +PLUSPAK bottle, 10 count, NDC 00407-1414-94
- Omnipaque solution for injection, GE Healthcare, 350 mg/mL, 50 mL +PLUSPAK bottle, 10 count, NDC 00407-1414-89
- Omnipaque solution for injection, GE Healthcare, 350 mg/mL, 500 mL +PLUSPAK bottle, 10 count, NDC 00407-1414-72
- Omnipaque solution for injection, GE Healthcare, 350 mg/mL, 75 mL fill in 100 mL +PLUSPAK bottle, 10 count, NDC 00407-1414-90

Reason for the Shortage

- GE Healthcare recalled Omnipaque 300 mg/mL 100 mL and 350 mg/mL 100 mL in late-April 2026 due to potential particulate contamination in the polymer bottles. Due to the resulting influx in demand, Omnipaque 300 mg/mL and 350 mg/mL products are on allocation.

Available Products

- Omnipaque oral solution, GE Healthcare, 12 mg/mL, 500 mL +PLUSPAK bottle, 10 count, NDC 00407-1416-12
- Omnipaque solution for injection, GE Healthcare, 180 mg/mL, 10 mL glass vial, 10 count, NDC 00407-1411-10
- Omnipaque solution for injection, GE Healthcare, 180 mg/mL, 20 mL glass vial, 10 count, NDC 00407-1411-20
- Omnipaque solution for injection, GE Healthcare, 240 mg/mL, 10 mL glass vial, 10 count, NDC 00407-1412-10
- Omnipaque solution for injection, GE Healthcare, 240 mg/mL, 100 mL +PLUSPAK bottle, 10 count, NDC 00407-1412-33
- Omnipaque solution for injection, GE Healthcare, 240 mg/mL, 20 mL glass vial, 10 count, NDC 00407-1412-20
- Omnipaque solution for injection, GE Healthcare, 240 mg/mL, 50 mL +PLUSPAK bottle, 10 count, NDC 00407-1412-30

Estimated Resupply Dates

- GE Healthcare has Omnipaque 300 mg/mL and 350 mg/mL products on allocation.

Updated

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.